Placebo-Controlled, Double-Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America
Clinical Infectious Diseases - United Kingdom
doi 10.1086/425007
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2004
Authors
Publisher
Oxford University Press (OUP)